Oxaliplatin News and Research

RSS
Modified form of chemotherapy before and after surgery enhances survival in pancreatic cancer patients

Modified form of chemotherapy before and after surgery enhances survival in pancreatic cancer patients

Study: Anti-inflammatory drug celecoxib benefits PIK3CA-mutated colon cancer patients

Study: Anti-inflammatory drug celecoxib benefits PIK3CA-mutated colon cancer patients

Immunotherapy-chemotherapy combo boosts survival for patients with metastatic colorectal cancer

Immunotherapy-chemotherapy combo boosts survival for patients with metastatic colorectal cancer

New treatment combination shows promise for metastatic colorectal cancer patients with rare genetic mutation

New treatment combination shows promise for metastatic colorectal cancer patients with rare genetic mutation

Exploring the link between drugs and microbiota: a growing imperative in precision medicine

Exploring the link between drugs and microbiota: a growing imperative in precision medicine

Subclonal neoantigens present a key roadblock in MMRd tumor immunotherapy success

Subclonal neoantigens present a key roadblock in MMRd tumor immunotherapy success

Amgen to discuss application for LUMAKRAS® (sotorasib) for the treatment of KRAS G12C-positive NSCLC at FDA advisory committee meeting

Amgen to discuss application for LUMAKRAS® (sotorasib) for the treatment of KRAS G12C-positive NSCLC at FDA advisory committee meeting

New targeted therapy zolbetuximab extends survival for patients with advanced gastric cancer

New targeted therapy zolbetuximab extends survival for patients with advanced gastric cancer

New anticancer agent activated by ultrasound waves does not have strong side effects

New anticancer agent activated by ultrasound waves does not have strong side effects

Four-drug chemotherapy regimen provides longer overall survival for metastatic pancreatic ductal adenocarcinoma

Four-drug chemotherapy regimen provides longer overall survival for metastatic pancreatic ductal adenocarcinoma

Study finds novel pathway for understanding why debilitating conditions happen for cancer patients

Study finds novel pathway for understanding why debilitating conditions happen for cancer patients

Researchers identify new drug that makes pancreatic cancer cells more vulnerable to chemotherapy

Researchers identify new drug that makes pancreatic cancer cells more vulnerable to chemotherapy

Researchers compare transcriptomic and cytokine responses of colorectal cancer cells

Researchers compare transcriptomic and cytokine responses of colorectal cancer cells

Discovery may enable the development of new therapies to kill aggressive cancer cells

Discovery may enable the development of new therapies to kill aggressive cancer cells

Study reveals potential risk factors for developing nerve damage after cancer treatment

Study reveals potential risk factors for developing nerve damage after cancer treatment

Combining PD-1 and VEGF inhibitors with chemotherapy can help control cholangiocarcinoma

Combining PD-1 and VEGF inhibitors with chemotherapy can help control cholangiocarcinoma

New approach can prevent aggressive operation in certain rectal cancer patients

New approach can prevent aggressive operation in certain rectal cancer patients

Study shows how Cisplatin chemotherapy leads to neuronal apoptosis

Study shows how Cisplatin chemotherapy leads to neuronal apoptosis

Immunotherapy benefits patients with gastric and esophageal cancers, new data shows

Immunotherapy benefits patients with gastric and esophageal cancers, new data shows

First clinical trial could become an effective way to deliver chemotherapy to abdominal cancer patients

First clinical trial could become an effective way to deliver chemotherapy to abdominal cancer patients

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.